Weikel W - Search Results

1

Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors.

Weikel W, Brumm C, Wilkens C, Beck T, Knapstein PG. Weikel W, et al. Cancer Detect Prev. 1995;19(5):446-50. Cancer Detect Prev. 1995. PMID: 7585732

2

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67.

Weikel W, Beck T, Mitze M, Knapstein PG. Weikel W, et al. Breast Cancer Res Treat. 1991 Aug;18(3):149-54. doi: 10.1007/BF01990030. Breast Cancer Res Treat. 1991. PMID: 1756257 Clinical Trial.

3

[Significance of neu-protein for prognosis of breast cancers].

Mitze M, Beck T, Weikel W, Rosenthal H, Knapstein PG. Mitze M, et al. Among authors: weikel w. Geburtshilfe Frauenheilkd. 1990 Oct;50(10):771-6. doi: 10.1055/s-2008-1026361. Geburtshilfe Frauenheilkd. 1990. PMID: 1981044 German.

4

[The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].

Weikel W, Beck T, Rosenthal H, Herzog R. Weikel W, et al. Geburtshilfe Frauenheilkd. 1989 Mar;49(3):277-82. doi: 10.1055/s-2008-1035754. Geburtshilfe Frauenheilkd. 1989. PMID: 2566552 German.

5

[Immunohistochemical detection and prognostic significance of p53 in the primary tumor of breast carcinoma patients].

Beck T, Weller E, Weikel W, Brumm C, Wilkens C, Knapstein PG. Beck T, et al. Among authors: weikel w. Geburtshilfe Frauenheilkd. 1995 May;55(5):252-7. doi: 10.1055/s-2007-1023313. Geburtshilfe Frauenheilkd. 1995. PMID: 7607381 German.

6

[Effect of the proliferation rate on the course of node negative breast carcinoma].

Mitze M, Weikel W, Brumm C, Lippold R, Knapstein PG. Mitze M, et al. Among authors: weikel w. Geburtshilfe Frauenheilkd. 1995 Jun;55(6):299-305. doi: 10.1055/s-2007-1023323. Geburtshilfe Frauenheilkd. 1995. PMID: 7657137 German.

7

Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1.

Beck T, Weller EE, Weikel W, Brumm C, Wilkens C, Knapstein PG. Beck T, et al. Among authors: weikel w. Gynecol Oncol. 1995 Apr;57(1):96-104. doi: 10.1006/gyno.1995.1104. Gynecol Oncol. 1995. PMID: 7705708

8

[Recent prognostic factors in vulvar carcinoma: histological, immunohistochemical and flow cytometry studies].

Weikel W, Beck T, Moll R, Brumm C, Knapstein PG. Weikel W, et al. Gynakol Geburtshilfliche Rundsch. 1995;35 Suppl 1:11-4. doi: 10.1159/000272556. Gynakol Geburtshilfliche Rundsch. 1995. PMID: 8672907 German.

9

Surgical therapy of recurrent vulvar cancer.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Koelbl H. Weikel W, et al. Am J Obstet Gynecol. 2006 Nov;195(5):1293-302. doi: 10.1016/j.ajog.2006.03.049. Epub 2006 May 8. Am J Obstet Gynecol. 2006. PMID: 16681985

10

[Posterior exenteration with plastic reconstruction in advanced vulvar cancer].

Weikel W, Güldütuna S, Knapstein PG, Mitze M. Weikel W, et al. Geburtshilfe Frauenheilkd. 1991 Oct;51(10):814-8. doi: 10.1055/s-2008-1026215. Geburtshilfe Frauenheilkd. 1991. PMID: 1761170 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters